Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-09

FDA Approved: ALMOTRIPTAN MALATE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Almotriptan Malate from Mylan as an original application generic product for the acute treatment of migraine in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Almotriptan malate (almotriptan)

Snippet

ORIG AP for ALMOTRIPTAN MALATE (ALMOTRIPTAN)